MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver.

by Erkko Ylösmäki, Sergio Lavilla-Alonso, Sari Jäämaa, Markus Vähä-Koskela, Taija af Hällström, Akseli Hemminki, Johanna Arola, Heikki Mäkisalo, Kalle Saksela
Published 2013-01-01

GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses

by Firas Hamdan, Beatriz Martins, Michaela Feodoroff, Yvonne Giannoula, Sara Feola, Manlio Fusciello, Jacopo Chiaro, Gabriella Antignani, Mikaela Grönholm, Erkko Ylösmäki, Vincenzo Cerullo
Published 2021-03-01

Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy.

by Leena Ylösmäki, Beatrice Polini, Sara Carpi, Beatriz Martins, Elena Smertina, Sara Feola, Manlio Fusciello, Karita Peltonen, Paola Nieri, Erkko Ylösmäki, Vincenzo Cerullo
Published 2019-01-01

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella

by Manlio Fusciello, Erkko Ylösmäki, Sara Feola, Arttu Uoti, Beatriz Martins, Karri Aalto, Firas Hamdan, Jacopo Chiaro, Salvatore Russo, Tapani Viitala, Vincenzo Cerullo
Published 2022-06-01

Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy

by Karita Peltonen, Sara Feola, Husen M. Umer, Jacopo Chiaro, Georgios Mermelekas, Erkko Ylösmäki, Sari Pesonen, Rui M. M. Branca, Janne Lehtiö, Vincenzo Cerullo
Published 2021-07-01

ANKRD54 preferentially selects Bruton's Tyrosine Kinase (BTK) from a Human Src-Homology 3 (SH3) domain library.

by Manuela O Gustafsson, Dara K Mohammad, Erkko Ylösmäki, Hyunseok Choi, Subhash Shrestha, Qing Wang, Beston F Nore, Kalle Saksela, C I Edvard Smith
Published 2017-01-01

Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin

by Sara Feola, Manlio Fusciello, Beatriz Martins, Erkko Ylösmäki, Vincenzo Cerullo, Tapani Viitala, Firas Hamdan, Jacopo Chiaro, Leena Ylösmäki, Matthew J Vaughan, Prasad S Kulkarni
Published 2021-07-01

Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses

by Firas Hamdan, Michaela Feodoroff, Salvatore Russo, Manlio Fusciello, Sara Feola, Jacopo Chiaro, Gabriella Antignani, Francesca Greco, Jeanette Leusen, Erkko Ylösmäki, Mikaela Grönholm, Vincenzo Cerullo
Published 2023-03-01

Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine

by Sara Feola, Sara Feola, Sara Feola, Sara Feola, Salvatore Russo, Salvatore Russo, Salvatore Russo, Salvatore Russo, Beatriz Martins, Beatriz Martins, Beatriz Martins, Beatriz Martins, Alessandra Lopes, Gaëlle Vandermeulen, Vinciane Fluhler, Vinciane Fluhler, Vinciane Fluhler, Vinciane Fluhler, Camilla De Giorgi, Camilla De Giorgi, Camilla De Giorgi, Camilla De Giorgi, Manlio Fusciello, Manlio Fusciello, Manlio Fusciello, Manlio Fusciello, Sari Pesonen, Erkko Ylösmäki, Erkko Ylösmäki, Erkko Ylösmäki, Erkko Ylösmäki, Gabriella Antignani, Gabriella Antignani, Gabriella Antignani, Gabriella Antignani, Jacopo Chiaro, Jacopo Chiaro, Jacopo Chiaro, Jacopo Chiaro, Firas Hamdan, Firas Hamdan, Firas Hamdan, Firas Hamdan, Michaela Feodoroff, Michaela Feodoroff, Michaela Feodoroff, Michaela Feodoroff, Mikaela Grönholm, Mikaela Grönholm, Mikaela Grönholm, Mikaela Grönholm, Vincenzo Cerullo, Vincenzo Cerullo, Vincenzo Cerullo, Vincenzo Cerullo, Vincenzo Cerullo
Published 2022-04-01

Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform

by Erkko Ylösmäki, Leena Ylösmäki, Manlio Fusciello, Beatriz Martins, Petra Ahokas, Hanne Cojoc, Arttu Uoti, Sara Feola, Anna Kreutzman, Tuuli Ranki, Julia Karbach, Tapani Viitala, Petri Priha, Elke Jäger, Sari Pesonen, Vincenzo Cerullo
Published 2021-03-01

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

by Sara Feola, Jacopo Chiaro, Beatriz Martins, Salvatore Russo, Manlio Fusciello, Erkko Ylösmäki, Chiara Bonini, Eliana Ruggiero, Firas Hamdan, Michaela Feodoroff, Gabriella Antignani, Tapani Viitala, Sari Pesonen, Mikaela Grönholm, Rui MM Branca, Janne Lehtiö, Vincenzo Cerullo
Published 2022-03-01

Artificially cloaked viral nanovaccine for cancer immunotherapy

by Manlio Fusciello, Flavia Fontana, Siri Tähtinen, Cristian Capasso, Sara Feola, Beatriz Martins, Jacopo Chiaro, Karita Peltonen, Leena Ylösmäki, Erkko Ylösmäki, Firas Hamdan, Otto K. Kari, Joseph Ndika, Harri Alenius, Arto Urtti, Jouni T. Hirvonen, Hélder A. Santos, Vincenzo Cerullo
Published 2019-12-01

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vi...

by Sara Feola, Manlio Fusciello, Beatriz Martins, Erkko Ylösmäki, Vincenzo Cerullo, Firas Hamdan, Jacopo Chiaro, Yvonne Giannoula, Maeve Long, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Otto Kari, Petrus Järvinen, Harry Nisen, Anna Kreutzman, Satu Mustjoki, Thomas G McWilliams, Mikaela Grönholm, Moon Hee Lee
Published 2021-08-01